Pharmacokinetics of tamsulosin in subjects with normal and varying degrees of impaired renal function: an open-label single-dose and multiple-dose study-Reference-Cited by-同舟云学术

Pharmacokinetics of tamsulosin in subjects with normal and varying degrees of impaired renal function: an open-label single-dose and multiple-dose study

Published:1998-07-06 Issue:4 Volume:54 Page:367-373
ISSN:0031-6970
Container-title:European Journal of Clinical Pharmacology
language:
Short-container-title:European Journal of Clinical Pharmacology

Author:

Wolzt M.,Fabrizii V.,Dorner G. T.,Zanaschka G.,Leufkens P.,Krauwinkel W. J. J.,Eichler H.-G.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Pharmacology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s002280050477.pdf

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Population pharmacokinetics of tamsulosine in patients with benign prostatic hyperplasia;World Journal of Urology;2024-07-22

2. Physiologically based pharmacokinetic (PBPK) modelling of tamsulosin to related CYP2D6*10 allele;ARCH PHARM RES;2021

3. Physiologically based pharmacokinetic (PBPK) modelling of tamsulosin related to CYP2D6*10 allele;Archives of Pharmacal Research;2021-11

4. Recommandations françaises du Comité de transplantation de l’association française d’urologie (CTAFU) : symptômes du bas appareil urinaire et incontinence urinaire chez le patient transplanté ou en attente de transplantation rénale;Progrès en Urologie;2021-01

5. Pharmacokinetics and tolerability of fedratinib, an oral, selective Janus kinase 2 inhibitor, in subjects with renal or hepatic impairment;Cancer Chemotherapy and Pharmacology;2020-05-24